Russia’s personalized mRNA-based cancer vaccine, Enteromix, has achieved 100% efficacy and safety in early clinical trials targeting colorectal cancer. Developed using COVID-19 vaccine technology, it’s now awaiting regulatory approval.
Unbiased. Unfiltered. Unstoppable